About 64% of the global population under age 50 has HSV-1, the virus most commonly associated with oral herpes (cold sores). That translates to roughly 3.8 billion people worldwide, based on 2020 estimates from the World Health Organization. In the United States, the number is lower and has been falling steadily.
Global Prevalence
HSV-1 is one of the most widespread infections on the planet. The WHO’s most recent estimates put the global infection rate at 64% of people under 50. Most of these infections are oral, picked up during childhood through casual contact like a kiss from a family member or sharing utensils. In lower-income regions, childhood infection rates tend to be higher, meaning a larger share of the population carries the virus by adulthood.
Prevalence in the United States
The U.S. has seen a notable decline. CDC survey data covering 2015 to 2016 found that HSV-1 prevalence among people aged 14 to 49 had dropped by about 11 percentage points compared to 1999, when it stood at 59.4%. That decline appeared across all racial and ethnic groups tracked: from 52.4% to 36.9% among non-Hispanic white individuals, 68.4% to 58.8% among non-Hispanic Black individuals, and 82.0% to 71.7% among Mexican-American individuals.
The likely explanation is improved hygiene and smaller household sizes, which reduce the chance of picking up HSV-1 in early childhood. That sounds like straightforwardly good news, but it has an unexpected flip side.
Why Declining Rates Created a New Problem
When fewer people catch HSV-1 as children, more young adults enter their sexually active years without any prior exposure to the virus, and therefore without any immunity. This has made HSV-1 an increasingly common cause of genital herpes, particularly in high-income countries like the U.S., Canada, and those in Western Europe. In these regions, HSV-1 has become the leading cause of first-episode genital herpes among adolescents and young adults, overtaking HSV-2 (the type traditionally associated with genital infections). In Africa, Latin America, and Southeast Asia, where childhood exposure remains high, HSV-2 still dominates genital herpes cases.
Most People Never Know They Have It
Roughly 90% of people with herpes (including both HSV-1 and HSV-2) never develop noticeable symptoms. You can carry HSV-1 for decades without ever getting a cold sore. This is why the infection is so widespread: people pass it along without realizing they have it.
Even without symptoms, the virus can still be shed from the skin or mucous membranes. Research from the University of Washington tracked people with genital HSV-1 infections and found they shed the virus on about 12% of days in the first two months after infection. By 11 months, that dropped to 7% of days. Among those who continued to shed at higher rates, a follow-up two years after infection found shedding had fallen to just 1.3% of days. Most shedding episodes happened without any visible sores or symptoms.
This declining pattern is specific to genital HSV-1. It tends to shed less frequently and recur less often than genital HSV-2, which means the long-term transmission risk is lower.
How HSV-1 Testing Works
HSV-1 is detected through a blood test that looks for antibodies your immune system produces in response to the virus. These tests are generally reliable once antibodies have had time to develop: one widely used test showed 94% sensitivity and 96% specificity. The catch is timing. If you’ve been recently infected, blood tests will often miss it. In one study, roughly 77% to 85% of blood tests came back falsely negative when taken within the first 30 days of infection. The median time for antibodies to reach detectable levels was about 25 days, meaning even at that point, only about half of newly infected people would test positive.
If you’re getting tested because of a new sore, a direct swab of the lesion is more accurate during the early stages. Blood tests are better suited for detecting a long-standing infection you may not have known about.
What These Numbers Mean in Context
HSV-1 is extraordinarily common, and the majority of carriers live without symptoms or complications. The global rate of 64% means that if you’re in a room with five people, statistically three of them carry the virus. In the U.S., the rate among 14- to 49-year-olds is lower (likely in the high 40s by now, given the downward trend), but it still represents tens of millions of people. For most, HSV-1 amounts to an occasional cold sore at worst, and for the vast majority, no symptoms at all.